HSPB1 rs39862642: Understanding Pharmacogenomic Associations
The rs39862642 variant is a genetic change located within the HSPB1 gene, which encodes a protein involved in cellular stress responses. Research has investigated this variant for potential associations with hematological toxicity in patients undergoing specific lung cancer treatments.
What each genotype means
Typical risk profile
This genotype represents the most common genetic sequence at this position in the HSPB1 gene. Research into this variant suggests an association with hematological toxicity risk in certain lung cancer treatment contexts, but individuals with this genotype do not carry the specific variant allele linked to that increased risk. Please discuss your treatment plan and any concerns regarding potential side effects with your oncologist or pharmacist.
This is the most common genotype observed in most global populations.
Increased toxicity risk
Carrying one copy of the T allele is associated with a statistically higher risk of developing hematological toxicity when undergoing specific chemotherapy regimens for lung cancer. This association is based on clinical studies, though individual responses to treatment can vary significantly based on other genetic and environmental factors. You should discuss this finding with your clinician or pharmacist to determine if it impacts your personalized treatment monitoring.
The frequency of this genotype varies by ancestry and is generally less common than the homozygous reference genotype.
Elevated toxicity risk
Carrying two copies of the T allele is associated with an increased risk of hematological toxicity during lung cancer treatment compared to those without the variant. While this association has been observed in clinical research, it is not a definitive predictor of how you will respond to medication. Please consult with your healthcare provider or pharmacist to review your treatment options and discuss appropriate clinical monitoring.
This genotype is relatively rare across most studied populations.
Understanding the HSPB1 Gene
The HSPB1 gene provides instructions for producing a protein known as heat shock protein 27 (HSPB1). This protein acts as a molecular chaperone, helping other proteins fold correctly and protecting cells from various forms of stress, including heat, oxidative damage, and toxic substances. In the context of oncology, HSPB1 is frequently studied because it can influence how cancer cells survive and respond to therapies. By stabilizing the cellular environment, HSPB1 often helps cells resist apoptosis, or programmed cell death, which is a mechanism that many cancer treatments aim to trigger. Because of its role in cytoprotection, researchers are interested in how variations in this gene might influence a patient's individual response to chemotherapy or radiation, as well as their susceptibility to side effects.
What is the rs39862642 Variant?
The rs39862642 variant is a single nucleotide polymorphism (SNP) located within the genomic region of the HSPB1 gene. SNPs are the most common type of genetic variation in humans, representing a difference in a single DNA building block, or nucleotide. When a variant occurs in a gene, it may potentially alter the expression levels of the protein or the structure of the protein itself. In pharmacogenomics, researchers look for these specific changes to see if they correlate with how a person processes a medication or how their body reacts to the physiological stress of a treatment regimen. While the presence of a variant does not guarantee a specific clinical outcome, it serves as a marker that scientists use to study biological variability in drug response and toxicity profiles across different patient populations.
Research and Clinical Evidence
Evidence regarding rs39862642 is currently categorized as moderate in the context of pharmacogenomics. Published studies have explored whether this variant influences the risk of hematological toxicity—a condition where blood cell counts drop—in patients receiving treatment for lung cancer. The rationale behind these studies is that if HSPB1 levels are altered by genetic variation, the body's ability to manage the stress of chemotherapy or radiation might also be affected. However, it is important to note that genetic associations are complex. Many factors, including age, overall health, concurrent medications, and the specific type of cancer treatment, contribute to the risk of side effects. Current research is ongoing, and findings from one study may not always be replicated in larger or more diverse cohorts. Consequently, this information is intended for educational purposes and should not be used to predict individual clinical outcomes.
Interpreting Your Genetic Information
If you have information about your genotype for rs39862642, it is essential to understand that this is only one small piece of a much larger biological puzzle. Genetic variants are not diagnostic tools; they are statistical markers that indicate a potential trend observed in research populations. You cannot and should not use this information to make decisions about your medical care, such as changing a dosage or stopping a treatment. If you are concerned about potential side effects of a medication, the most important step is to have an open conversation with your oncologist or pharmacist. They are equipped to evaluate your entire clinical picture, including your medical history and current treatment plan, to provide personalized guidance. Always consult with your healthcare team before drawing conclusions based on genetic data.
How common is this variant?
Specific population frequency data for rs39862642 is not widely documented in major public databases. Frequency can vary significantly across different ancestral groups, and further large-scale genomic studies are required to establish precise prevalence.
Frequently asked questions
Can I use this SNP to predict if I will get sick from chemotherapy?
No. Genetic variants like rs39862642 are only statistical associations and cannot predict individual outcomes. Many factors, including your overall health and the specific drugs used, play a much larger role in determining side effects.
What should I do if I have the 'higher-attention' genotype?
You should continue your treatment as prescribed and discuss any concerns with your doctor. Genetic information should never be used to alter your medical treatment without professional clinical oversight.
Is this variant found in all populations?
Genetic variants are often distributed differently across various ancestral groups. Without specific data for rs39862642, it is difficult to determine its exact prevalence in any single population.
Where can I find more information about HSPB1?
You can search for the gene name 'HSPB1' on resources like MedlinePlus Genetics or the NCBI Gene database. These sites provide comprehensive, peer-reviewed information about gene functions and their roles in human health.
Sources & further reading
Educational information only, last refreshed 10/9/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs39862642?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29